PayerTalkCE

This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://managedcareeye.com/preventing-blindness. This podcast will highlight challenges across the patient journey—including access to care, benefit design, and coverage decision-making—and their impact on timely diagnosis and treatment. The expert faculty will share payer perspectives on current coverag...

This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/mg-management. Managed care professionals face unique challenges in optimizing outcomes for patients with MG, a rare, chronic autoimmune neuromuscular disorder characterized by fluctuating muscle weakness and fatigue. The increasing prevalence and complexity of MG, combined with...

This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.managedcareeye.com/bridging-the-gaps/. This podcast will examine how payer policies shape the real world management of diabetic retinopathy (DR), diabetic macular edema (DME), and age related macular degeneration (AMD), highlighting health care provider insights on the systemic challenges tha...

This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/asthma-management-best-practices/. Asthma remains a major public health issue in the US, with many patients still uncontrolled despite available treatments and evidence-based guidelines. This leads to preventable ER visits, hospitalizations, and significant costs—over $80 billio...

This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.managedcareeye.com/aligning-policy-with-practice/. Within the space of just a few years, several new retinal treatments have been approved promising increased durability and better patient outcomes. These conditions can significantly impact vision and quality of life for patients. This webcas...

This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/hypertrophic-cardiomyopathy-payertalkce/. Through a multidisciplinary discussion format, the podcast will address critical gaps in payer understanding of hypertrophic cardiomyopathy (HCM), including guideline interpretation, coverage implications, emerging pharmacologic options...

In this episode of PayerTalkCE®, we will delve into the innovations around HER2-targeting therapies and their role in the treatment of select gastrointestinal cancers. Topics will include the latest evidence and the integration of new treatments into health care systems, insurance coverage, reimbursement challenges, and the overall impact on health care policy. This activity is certified for CME/C...

In this episode of PayerTalkCE® we will explore the epidemiology and burdens of gastroesophageal and biliary tract cancers. Experts will discuss the importance of early and accurate diagnosis in managing treatment efficacy and cost. The episode will also delve into the role of personalized medicine and multidisciplinary approaches and provide collaborative and actionable insights on how managed ca...

This podcast explores macular telangiectasia (MacTel), a rare and progressive retinal disease, with a focus on advancing early detection, appropriate treatment, and health system coordination. Retina specialist Dr. Jay Chhablani discusses the shift in understanding MacTel as a neurodegenerative—not vascular—condition, highlighting the limitations of anti-VEGF therapy and the significance of a newl...

This podcast highlights opportunities for managed care organizations to improve COPD management by aligning coverage policies with current clinical evidence and treatment guidelines. Experts discuss new therapies, including recently approved biologics and inhaled agents, and their roles in treating patients with frequent exacerbations or type 2 inflammation. The session also addresses implementati...

This podcast features expert discussion on the emerging role of type 2 (T2) inflammation in chronic obstructive pulmonary disease (COPD) and the implications for payer and provider decision-making. Faculty review key pathophysiologic mechanisms and biomarkers—particularly eosinophil counts—that identify patients most likely to benefit from targeted biologic therapies. The conversation also explore...

This podcast reviews a case-based discussion on managing age-related macular degeneration (AMD), a leading cause of blindness among older adults, particularly those enrolled in Medicare Advantage plans. Experts review the progression of AMD, key diagnostic tools, and the importance of timely anti-VEGF therapy to prevent vision loss. The conversation highlights payer considerations, including step...

This podcast explores the challenges of managing diabetic retinopathy in patients with type 1 diabetes, focusing on a case study of a working-age patient with barriers to care. Expert insights highlight the importance of early screening, timely intervention, and payer strategies to facilitate access to specialty care. Discussion covers diagnostic approaches, treatment selection, and the role of an...

This podcast provides health plan professionals with expert insights on best practices for managing moderate to severe asthma, focusing on type 2 inflammation. Discussion topics include current treatment guidelines, the role of biomarkers in therapy selection, and the impact of biologics on reducing exacerbations and healthcare utilization. Experts also examine challenges in asthma management, suc...

This podcast provides health plan professionals with an in-depth discussion on the role of type 2 (T2) inflammation in asthma pathophysiology and the evolving treatment landscape. Experts explore the mechanisms driving T2 inflammation and how biomarkers can help guide therapy selection. The conversation highlights biologic treatments' clinical and economic considerations, including their impact on...

This podcast explores payer best practices in managing atopic dermatitis, emphasizing the role of type 2 inflammation and its impact on patient outcomes. Experts discuss current treatment guidelines, the efficacy of emerging therapies, and strategies for tailoring care to patient needs, including those with darker skin tones. Key barriers such as access to dermatologists, treatment complexity, and...

This podcast provides an in-depth exploration of type 2 inflammation and its role in the pathophysiology and management of atopic dermatitis, tailored for health plan professionals. Experts discuss the molecular mechanisms driving the condition, including key cytokines like IL-4 and IL-13, and highlight the clinical and quality-of-life impacts for patients. The conversation covers the evolution of...

This PayerTalkCE podcast, hosted by Dana McCormick and Dr. Jordan Graff, focuses on managing diabetic retinopathy (DR) and diabetic macular edema (DME) in underserved populations. Key challenges include limited access to care, transportation, and socioeconomic barriers. They highlight the importance of early intervention, remote screening technologies, and advancements in anti-VEGF therapies to re...

In this PayerTalkCE podcast, Dr. Gary Owens and Dr. Adrienne Scott discuss the care coordination challenges and treatment strategies for patients with age-related macular degeneration (AMD) and comorbid conditions like hypertension and diabetes. They emphasize the importance of individualized therapy, including treat-and-extend protocols and balancing treatment burden with efficacy. Key challenges...

In this discussion, Dana McCormick, RPh, introduces a CE program on managing eosinophilic esophagitis (EoE) with insights from Dr. Evan Dellon and Dr. Drake Reiter. Dr. Dellon highlights advancements in EoE treatment guidelines, including new pharmacologic options, and stresses individualized care strategies. Dr. Reiter emphasizes the value of clinical guidelines for payers in managing EoE, aligni...

This podcast addresses the role of type 2 inflammation in the pathophysiology and management of eosinophilic esophagitis (EoE), with a focus on evolving treatment strategies. Dr. Evan Dellon discusses the mechanisms behind EoE, the limitations of current allergy testing, and the challenges in diagnosing the condition due to non-specific symptoms. He reviews current therapeutic approaches, includin...

This podcast focuses on improving equity in pediatric atopic dermatitis management, highlighting key challenges in access to care for children with moderate to severe cases. Dr. Joy Wan emphasizes the importance of timely referrals to dermatologists, noting the frustrations families face due to delays in treatment. She discusses the complexities of treatment, considering safety, efficacy, and the...

The podcast features an expert panel discussing trends and opportunities for continuous glucose monitoring (CGM) in managing diabetes within managed care. Dr. Timothy Gilbert emphasizes technological advancements in CGM, illustrating benefits in improving glycemic control and reducing diabetes-related complications. The conversation highlights CGM's role in patient engagement by providing real-tim...

This PayerTalkCE episode provides an in-depth examination of the management and treatment of Multiple Sclerosis (MS) from both a clinical and payer perspective. Experts discuss various MS subtypes, emphasizing the importance of tailored treatments based on individual patient needs and disease progression. Key considerations include drug efficacy, side effects, comorbidities, and the economic aspec...

To participate in this on-demand continuing education activity and earn credit, visit us at https://www.impactedu.net/psoriasis-advancements/. In this episode of PayerTalkCE you will learn about: Emerging and recently approved psoriasis therapies Strategies to improve and expedite access to high quality care Comorbidities, history, and patient preferences that influence therapeutic selection This...